Return to search

Dimorfismo sexual no modelo de infarto do mioc?rdio em ratos: aspectos neuroend?crinos e auton?micos cardiovasculares / Sexual dimorphism in the myocardial infarction model in rats: neuroendocrine and autonomic cardiovascular aspects

Submitted by Celso Magalhaes (celsomagalhaes@ufrrj.br) on 2017-05-03T14:02:59Z
No. of bitstreams: 1
2014 - Natalia Soares Carvalho de Souza.pdf: 1833535 bytes, checksum: 4574c94ab4a477d9f8d0ddf31d6b4069 (MD5) / Made available in DSpace on 2017-05-03T14:03:00Z (GMT). No. of bitstreams: 1
2014 - Natalia Soares Carvalho de Souza.pdf: 1833535 bytes, checksum: 4574c94ab4a477d9f8d0ddf31d6b4069 (MD5)
Previous issue date: 2014-08-26 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / Premenopausal women are less prone to develop cardiovascular diseases than men and
this advantage do not persist in postmenopausal women. Thus herein we aimed to
investigate the gender difference and the estrogen influence in cardiac function, fluid
balance and thyroid status, in Wistar rats subjected to experimental model of myocardial
infarction (MI).
In the first step, adult male (n = 18) and female (n = 21) rats underwent experimental
MI (MIm and MIf,) or sham-operation (ShamM and ShamF) respectively. One and four
weeks post-MI rats were placed in metabolic cages, subjected to echocardiography
(ECHO), electrocardiography and then euthanized for blood sample collection and
tissue collection (heart, lung and liver). In the second step female rats were
ovariectomized (n = 24) or continued intact (n = 21), two weeks later they were
subjected to MI (MIOVX and MIINT, respectively) or sham operation (ShamOVX and
ShamINT). Four weeks post-MI, they were subjected to the same evaluations of the first
step, not only the electrocardiography. In the third step, female rats were subjected to
ovariectomy and treated with estrogen (E2) (n = 13) or vehicle (n = 22). Two weeks
later they underwent experimental MI (MIOVX+E2 and MIOVX+Veh). Four weeks post-MI
they were subjected to the same evaluations of the second step.
Male infarcted rats developed cardiac dysfunction (shortening fraction, SF, reduction, ~
70%) and fluid homeostasis changes (sodium intake increasing, ~ 146% and urinary
volume reduction, ~55%) earlier than female, in the first week post-MI while female
presented these changes (SF reduction, ~28% and sodium intake increasing, ~143%)
only in the fourth week and attenuated compared to male. MIM showed reduction in
LF/HF ratio (~70%), one week post-MI. And only male rats presented hypothyroidism
after MI (T4 ~52% and T3 ~38%, reduction). We also verified reduction in SF (~55%),
increasing in LA/Ao ratio (~75%) and changes in fluid balance (sodium intake
reduction, ~67% and urinary volume reduction, ~40%) more pronounced in MIOVX than
in MIINT. MIOVX group reduced thyroid hormone levels after MI (T3 ~35%). MIOVX+Veh
showed more pronounced reduction in SF (~55%) and increasing in LA/Ao ratio
(~75%) than the MIOVX+E2 group. The sodium intake reduced in MIOVX+Veh (~67%) and
in the urinary volume we verified significant reduction in ShamOVX+Veh and MIOVX+Veh
groups compared to ShamOVX+E2 and MIOVX+E2 groups (P < 0.05). Serum T3 reduced
significantly (~35%) only in MIOVX+Veh group.
The pathophysiological development of heart failure post-MI was attenuated in female
compared to male. And female rats subjected to MI presented fluid balance more
favorable and related to the less pronounced development of heart failure. Estrogen
seems to influence positively the cardiac function and attenuate the dysfunction that
occur post-MI. The euthyroid status in female intact do not seems to be determinant to
the less pronounced development of heart failure / Sabe-se que mulheres na pr?-menopausa apresentam menor preval?ncia de doen?as
cardiovasculares do que homens e, esta diferen?a desaparece ap?s a menopausa. Sendo
assim, o presente estudo buscou avaliar o dimorfismo sexual e a influ?ncia do estr?geno
nas altera??es da fun??o card?aca, do equil?brio hidroeletrol?tico e do status tireoidiano
de ratos Wistar submetidos ao infarto do mioc?rdio (IM) experimental.
Na primeira etapa ratos wistar machos (n = 18) e f?meas (n = 21) foram submetidos ao
infarto experimental (INF.M e INF.F) ou ? falsa cirurgia (Sham.M e Sham.F). Na
primeira e quarta semana p?s-IM foram colocados em gaiolas metab?licas e submetidos
? ecodopplercardiografia (ECO) e eletrocardiografia (an?lise espectral), seguido de
eutan?sia para coleta de sangue (dosagem s?rica de horm?nios tireoidianos) e de tecidos
(cora??o, pulm?o e f?gado, para biometria). Na segunda etapa, f?meas foram
ovariectomizadas (n = 24) ou mantidas intactas (n = 21) e ap?s duas semanas
submetidas ao infarto do mioc?rdio (INFOVX e INFINT) ou ? falsa cirurgia (ShamOVX e
ShamINT). Quatro semanas ap?s p?s-IM, as mesmas avalia??es da etapa anterior foram
realizadas exceto a eletrocardiogr?fica. Na terceira etapa, foi realizada ovariectomia e
reposi??o com estr?geno (E2) ( n = 13) ou ve?culo (n = 22). Ap?s duas semanas foi
realizada a cirurgia de indu??o ao infarto (INFOVX+E2 e INFOVX+Veic) e a falsa cirurgia
(ShamOVX+E2 e ShamOVX+Veic). Decorridas quatro semanas foram feitas as mesmas
avalia??es da segunda etapa.
O grupo INFM desenvolveu disfun??o card?aca (fra??o de encurtamento, FEnc%, ~70%
de redu??o) e altera??es na regula??o hidroeletrol?tica (aumento do apetite por s?dio,
~146% e redu??o do volume urin?rio, ~55%), uma semana p?s-IM e, portanto, mais
cedo que as f?meas, que apresentaram altera??es na fun??o card?aca (FEnc%, ~28% de
redu??o) e regula??o hidroeletrol?tica (aumento do apetite por s?dio, ~143%) na quarta
semana p?s-IM. O grupo INFM apresentou redu??o na rela??o LF/HF (~70%), uma
semana p?s-IM. E, apenas os ratos machos desenvolveram hipotireoidismo ap?s o
infarto. Tamb?m foi observada redu??o da FEnc% (~55%), aumento da rela??o ?trio
esquerdo/ aorta (AE/Ao, ~75%) e altera??es na regula??o hidroeletrol?tica (redu??o do
apetite por s?dio, ~67% e do volume urin?rio, ~40%) mais pronunciadas em INFOVX do
que em INFINT. O grupo INFOVX tamb?m apresentou redu??o dos n?veis s?ricos de T3
(~35%) p?s-IM. O grupo INFOVX+Vei mostrou redu??o da FEnc% (~55%) e aumento na
rela??o AE/Ao (~75%) mais pronunciadas que o grupo INFOVX+E2. INFOVX+Vei reduziu o
apetite por s?dio (~67%) e, no volume urin?rio, foi observada redu??o significativa nos
grupos ShamOVX+Vei e INFOVX+Vei em rela??o aos grupos ShamOVX+E2 e INFOVX+E2
(P<0,05). O T3 s?rico reduziu significativamente (~35%) apenas no grupo INFOVX+Vei.
Houve diferen?a no desenvolvimento fisiopatol?gico da insufici?ncia card?aca (IC) p?s-
IM entre machos e f?meas, sendo mais brando nas f?meas. E f?meas infartadas
apresentaram uma regula??o hidroeletrol?tica mais favor?vel e compat?vel com o
desenvolvimento menos acentuado da IC. O estr?geno influenciou positivamente a
regula??o hidroeletrolitica de f?meas infartadas, o que favoreceu a fun??o card?aca e
atenuou desta forma, a disfun??o que ocorre ap?s o infarto. A manuten??o do status
eutire?ideo n?o pareceu ser determinante para o desenvolvimento menos pronunciado
da IC

Identiferoai:union.ndltd.org:IBICT/oai:localhost:jspui/1574
Date26 August 2014
CreatorsSouza, Natalia Soares Carvalho de
ContributorsOlivares, Emerson Lopes, Fonseca, Fab?cia Viana, Fonseca, Fab?cia Viana, Almeida, Norma Aparecida dos Santos, Almeida, Norma Aparecida dos Santos
PublisherUniversidade Federal Rural do Rio de Janeiro, Programa Multic?ntrico de P?s-Gradua??o em Ci?ncias Fisiol?gicas, UFRRJ, Brasil, Instituto de Ci?ncias Biol?gicas
Source SetsIBICT Brazilian ETDs
LanguagePortuguese
Detected LanguageEnglish
Typeinfo:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis
Formatapplication/pdf
Sourcereponame:Biblioteca Digital de Teses e Dissertações da UFRRJ, instname:Universidade Federal Rural do Rio de Janeiro, instacron:UFRRJ
Rightsinfo:eu-repo/semantics/openAccess
Relation8. REFER?NCIAS BIBLIOGR?FICAS ADAMS, S.; WILLIAMS, V.; VESSEY, M. P; Cardiovascular disease and hormone replacement treatment: a pilot case-control study. Br Med J (clin Res. Ed.).v.282, p. 1277-1278, 1981. AGABITI, R. E.; Left ventricular hypertrophy and heart failure in women. J Hypertens Suppl.v.20, S34-8,2002. ALEXANDERSEN, P.; TANKO, L.B.; BAGGER, Y.Z.; QIN, G.; CHRISTIANSEN, C. The long ? term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Climacteric. v.9, p. 108 ? 118, 2006. 78 ANTUNES-RODRIGUES, J.; COVIAN, M. R. Hypothalamic controlo f sodium chloride and water intake. Acta Physiol Lat Am, 13:94-100, 1963. ANTUNES-RODRIGUES, J.; CASTRO, M.; ELIAS, L. L. K.; VALEN?A, M. M.; McCANN, S. M.. Neuroendocrine Control of Body Fluid Metabolism. Physiol Rev 84: 169?208, 2004. ANVERSA, P.; BEGHI, C.; McDONALD, S.L.; LEVICKY, V.; KIKKAWA, Y.; OLIVETTI, G. Morphometry of right ventricular hypertrophy induced by myocardial infarction in the rat. American Journal of Pathology 116(3): 504-513, 1984. ANVERSA, P.; BEGHI, C.; KIKKAWA, Y.; OLIVETTI, G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy and capillary growth. Circ Res 58(1): 26-37, 1986. AUBERT, A. E., S. Vandeput, et al. Complexity of cardiovascular regulation in small animals. Philos Transact A Math Phys Eng Sci, v.367, n.1892, Apr 13, p.1239-50. 2009. BABIKER, F. A.; DE WINDT, L. J.; VAN EICKELS, M.; THIJSSEN, V.; BRONSAER, R. J.; GROHE, C.; VAN BILSEN, M.; DOEVENDANS, P.A. 17(Beta) estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylylcyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation.v.109, p. 269-276, 2004. BADAU?-PASSOS, D. Jr.; VENTURA, R. R.; SILVA, L. F.; OLIVARES, E. L.; RAMALHO, M. J.; ANTUNES-RODRIGUES, J.; REIS, L. C. Effect of losartan on sodium appetite of hypothyroid rats subjected to water and sodium depletion and water, sodium and food deprivation. Exp Physiol. Sep;86(5):621-8, 2001. BARRETT-CONNOR, E. Sex differences in coronary heart disease: why are women so superior? Circulation.v.95, p.252 ? 264, 1997. BEER J.C, ZELLER M, DENTAN G, LAURENT Y, L?HUILLIER I, RAVISY J, SICARD P, VINCENT-MARTIN M, MAKKI H, RIOUFOL G, FINET G, COTTIN Y. Predictors and prognosis for complex coronary lesions in patients with acute myocardial infarction: data from RICO survey. Am Heart J 154:330-5, 2007. 79 BELL?, A. A. & COVIAN, M. R. (1988). Effect of the excess of thyroid hormone administration on water and sodium chloride intake in the rat. Physiology and Behavior 43, 155?157. BESTER, A.J.; BAJUSZ, E.; LOCHNER, A. Effect of ischemia and infarction on the metabolism and function of the isolated, perfused rat heart. Cardiovascular Research 6: 284-294, 1972. BIANCO, A.C.; SALVATORE, D.; GEREBEN, B.; BERRY, M.J.; LARSEN, P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronineselenodeiodinases. Endocrine Reviews 23:38-89, 2002. BIANCO AC & KIM BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest, 116: 2571-9, 2006. BIGGER JR. J. T., FLEISS J. L., ROLNITZKY L. M., STEINMAN R. C., SCHNEIDER W. J. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 1991;18:1643 ? 9. BLOM, M. J.; WASSINK, M. G.; KLOOSTERBOER, H. J.; EDERVEEN, A. G. H.; LAMBERT, J. G. D.; GOOS, H. J. T. H. Metabolism of estradiol, ethynilestradiol, and moxestrol in rat uterus, vagina, and aorta: influence of sex esteroid treatment. Drug Metabolism and Disposition.v. 29,n.1, p.76-81, 2001 BURRELL L. M.; PHILLIPS P. A.; RISVANIS J.; CHAN R. K.; ALDRED K. L.; JOHNSTON C. I. Long-term effects of nonpeptide vasopressin V2 antagonist OPC- 31260 in heart failure in the rat. Am J Physiol Heart Circ Physiol 275: H176?H182, 1998. BUTTRICK, P. & SCHEUER, J. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation v.86, p.1336-1338,1992. CAMM A. J., PRATT C. M., SCHWARTZ P. J. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation;109:990 ? 6, 2004. 80 CAMPER-KIRBY, D.; WELCH, S.; WALKER, A.; SHIRAISHI, I.; SETCHELL, K. D. R; SCHAEFER, E.; KAJSTURA, J; ANVERSA, P.; SUSSMAN, M. A.; Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res. v.88, p.1020?1027, 2001. CARLBERG, K. A.; FREGLY, M. J.; FAHEY, M. Effects of chronic estrogen treatment on water exchange in rats. Am J Physiol,; 247: 101-110, 1984. CARPEGGIANI C., EMDIN M., BONAGUIDI F. Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction. Eur Heart J 26:1612 ? 7, 2005. CAVASIN, M. A.; SANKEY, S. S.; YU, A. L.; MENON, S.; YANG, X. P. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284, H1560?H1569, 2003. CAVASIN, M. A.; TAO, Z.; MENON, S.; YANG, X. P. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci; 75:2181?92, 2004. CHEN, H.J.; WALFISH, P.G. Effects of estradiol benzoate on thyroid-pituitary function in female rats. The Endocrine Society 103(4): 1023-1030, 1978(a). CHEN, H.J.; WALFISH, P.G. Effects of age and ovarian function on the pituitarythyroid system in female rats. J. Endocrinology 78: 225-232, 1978(b). CHEN, H.J. Age and sex difference in serum and pituitary thyrotropin concentrations in the rat: influence by pituitary adenoma. Experimental Gerontology 19: 1-6, 1984. CHOPRA, I. J. Euthyroid sick syndrome: is it a misnomer. J Clin Endocrinol Metab 82:329?334, 1997. CHRISTIANSON, D.; ROTI, E.; VAGENAKIS, A.G.; BRAVERMAN, L.E. The sexrelated difference in serum thyrotropin concentration is androgen mediated. Endocrinology 108:529-535, 1981. 81 CLELAND, J. G.; SWEDBERG, K.; FOLLATH, F.; KOMAJDA, M.; COHENSOLAL, A.; AGUILAR, J. C.; DIETZ, R.; GAVAZZI, A.; HOBBS, R.; KOREWICKI, J.; MADEIRA, H. C.; MOISEYEV, V. S.; PREDA, I.; VANGILST, W. H.; WIDIMSKY, J.; FREEMANTLE, N.; EASTAUGH, J.; MASON, J.; STUDY GROUP ON DIAGNOSIS OF THE WORKING GROUP ON HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY. The EuroHeart Failure survey programme- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J, Mar; 24(5):442-63. COHN, J. N.; LEVINE, T. B.; OLIVARI, M. T.; GARBERG, V.; LURA, D. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819?823, 1984. CORR?A DA COSTA, V.M.; MOREIRA, D.G.; ROSENTHAL, D. Thyroid function and aging: gender-related differences. Journal of Endocrinology 171:193-198, 2001. COURNEYA, C.A. & KORNER PI. Neurohumoral mechanisms and the role of the arterial baroreceptores in the renovascular response to haemorrhage in rabbits. J Physiol (Lond) 437:393:407, 1991. CORR?A DA COSTA, V.M.; MOREIRA, D.G.; ROSENTHAL, D. Thyroid function and aging: gender-related differences. Journal of Endocrinology 171:193-198, 2001. CRANTZ, F.R.; SILVA, J.E.; LARSEN, P.R. An analysis of the sources and quantity of 3,5, 3?-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 110:367-375, 1982. CURTIS KS. Estrogen and the central control of body fluid balance. Physiol Behav;97:180?92, 2009. DANZI, S.; KLEIN, I. Thyroid hormone and the cardiovascular system. Med Clin Am 96: 257-268, 2012. DEAN, S. A.; TAN, J.; WHITE, R.; O?BRIEN, E. R.; LEENEN, F. H. H. 17?-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type I receptor in female rats. Am J Physiol Regul Integr Comp Physiol 288: R759-R766, 2004 82 DEAN, S. A.; TAN, J.; WHITE, R.; O?BRIEN, E. R.; LEENEN, F. H. H. Regulation of components of the brain and cardiac rennin-angiotensin systems by 17 ?-estradiol after myocardial infarction in female rats. Am J Physiol Regul Integr Comp Physiol 291:R162, 2006. DILLMAN W. H. Biochemical basis of thyroid hormone action in the heart. Am J Med 88:626-639, 1990. DONDA, A.; REYMOND, F.; REY, F.; LEMARCHAND-B?RAUD, T. Sex steroids modulate the pituitary parameters involved in the regulation of TSH secretion in the rat. ActaEndocrinologica 122: 577-584, 1990. DO-VALE, C. F.; SAADWA; RENZI, A.; CAMARGO, G. M.; QUEIROZ, R. C.; SILVEIRA, J. E.; MENANI, J. V.; CAMARGO, L. A. Progesterone administration to ovariectomized rats reduces water and salt intake induced by central administration of angiotensin II. Braz J Med Biol Res 28, 999?1002, 1995. EAKER, E. D.; CHESEBRO, J. H.; SACKS, F. M.; WENGER, N. K.; WHISNANT, J. P.; WINSTON, M. Cardiovascular disease in women. Circulation 88: 1999?2009, 1993. ELLIS, L.B.; ALLISON, R.B.; RODRIGUEZ, F.L.; ROBBINS, S.L. Relations of the degree of coronary artery disease and of myocardial infarctions to cardiac hypertrophy and chronic congestive heart failure. New England Journal of Medicine 266(11): 525-9, 1962. FACTOR SM. Pathophysiology of myocardial ischemia. In: HURST JW; SCHLANT, RC; RACKLEY CE; SONNENBLICK EH; WENGER NK, The heart. Arteries and veins. 7 ed. New York, McGraw-Hill, Cap. 49, p. 940-59, 1990. FALKENSTEIN, E.; TILLMANN, H. C.; CHRIST, M.; FEURING, M.; WEHLING, M. Multiple actions of steroid hormones?a focus on rapid, nongenomic effects. Pharmacol Rev; 52:513?56, 2000. FANNON, S. A.; VIDAVER, R. M.; MARTS, S. A. An abridged history of sex steroid hormone receptor action. J Appl Physiol; 91:1854?9, 2001. FARBOTA, L.; HOFMANN, C.; OSLAPAS, R.; PALOYAN, E. Sex hormone modulation of serum TSH levels. Surgery 102(6): 1081-1087, 1987. 83 FELDER, R. B.; FRANCIS, J.; ZHANG, Z.; WEI, S.; WEISS, R. M.; JOHNSON, A. K. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 284: R259?R276, 2003; 10.1152/ajpregu.00317, 2002. FELLENIUS, E.; HANSEN, C.A.; MJOS, O.; NEELY, J.R.Chronic infarction decreases maximum cardiac work and sensitivity of heart to extracellular calcium. Am J Physiol. 249 (1 Pt 2):H80-7, 1985. FERGUSON, D. W.; BERG, W. J.; SANDERS, J. S. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 16: 1125?1134, 1990. FISHBEIN, M.C.; MACLEAN, D; MAROKO, P.R. Experimental Myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am. J. Pathol., 90: 57-70, 1978a. FISHBEIN, M.C.; MACLEAN, D; MAROKO, P.R. The histologic evolution of the myocardial infarction. Chest 73: 843-9, 1978b. FLETCHER, P.J.; PFEFER, J.M.; PFEFFER, M.A., BRAUNWALD, E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function. Circulation Research 49(3): 618-26, 1981. FRANCIS, G. S. The relationship of the sympathetic nervous system and the reninangiotensin system in congestive heart failure. Am Heart J 118: 642?648,1989. FRANCIS, G. S. Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations. J Cardiovasc Pharmacol 32: S16?S21, 1998. FRANCIS, J.; WEISS, R.M.; WEI, S.G.; JOHNSON, A.K.; FELDER, R.B. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regulatory Integrative Comp Physiol 281: R1734-1745, 2001. 84 FRANCIS, J.; WEISS, R.M.; WEI, S.G.; JOHNSON, A.K.; BELTZ, T. G.; ZIMMERMAN, K.; FELDER, R.B. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol, 281: H2241-H2251, 2001. FRANKLYN JA; GAMMAGE MD; RAYMSDEN DB; SHEPPARD MC. Thyroid Status in Patients After Acute Myocardial Infarction. ClinSci (Colch) 67:585-590, 1984. FREGLY, M. J. & ROWLAND, N. E. Role of renin?angiotensin?aldosterone in NaCl appetite of rats. American Journal of Physiology 248, R1?11, 1985. FUKUDA, H.; GREER, M.; ROBERTS, L.; ALLEN, C.E.; CRITCHOLOW, V.; WILSON, M. Nyctohemeral and sex-related variations in plasma thyrotropin, thyroxine, and triiodotironine. Endocrinology 97: 1424-1430, 1975. GARDIN, J.M.; WAGENKNECHT, L.E.; ANTON, C. H.; FLACK, J.; GIDDING, S.; KUROSAKI, T.; WONG, N.D.; MANOLIO, T.A. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The cardia Study. Coronary Artery Risk Development in Young Adults. Circulation. v.92, p.380?387, 1995. GEREBEN, B.; SALVATORE, D.; HARNEY, J.W.; TU, H.M.; LARSEN, P.R. The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1). Molecular Endocrinology 15:112-124, 2001. GEREBEN B, ZAVACKI AM, RIBICH S, KIM BW, HUANG SA, SIMONIDES WS, ZE?LD A, BIANCO AC. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev, 29(7):898-938, 2008. GREELEY, G.H.; LIPTON, M.A.; KIZER, J.S. Serum thyroxine, triiodothyronine, and TSH levels and TSH release after TRH in aging male and female rats. Endocrine Research Communications 9:169-177, 1983. 85 GRADY, D.; RUBIN, S. M.; PETITTI, D. B.; FOX, C. S.; BLACK, D.; ETTINGER, B.; ERNSTER, V. L.; CUMMINGS, S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med.v. 117, p. 1016-1037, 1992. GRODSTEIN, F.; STAMPFER, M. J.; COLDITZ, G. A.; WILLETT, W. C.; MANSON, J. E.; JOFFE, M.; ROSNER, B.; FUCHS, C.; HANKINSON, S. E.; HUNTER, D. J.; HENNEKENS, C. H.; SPEIZER, F.E. Postmenopausal hormone therapy and mortality. N Engl J Med. v.336, p. 1769 ? 1775, 1997. GRODSTEIN, F.; MANSON, J. E.; COLDITZ, G.A.; WILLETT, W. C.; SPEIZER, F.E.; STAMPFER, M. J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.Ann Intern Med. v. 133, p. 933 ? 941, 2000. GROHE, C.; KAHLERT, S.; LOBBERT, K.; VAN EICKELS, M.; NEYSES, L.; STIMPEL, M.; VETTER, H. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J. Hyperten. v.16, p. 377 - 384, 1998. GROSSMAN, W; JONES, D.; MACLAURIN, L.P. Wall stress and patters of hypertrophy in the human left ventricle. J Clin invest 56: 56-64, 1975. GRUBER, D. M. & HUBER, J. C. Tissue specificity: the clinical importance of steroid metabolites in hormone replacement therapy. Maturitas. v. 37, p.151-157, 2001. GRUBER, C. J.; TSCHUGGUEL, W.; SCHNEEBERGER, C.; HUBER, J. C. Production and actions of estrogens. N Engl J Med. 31;346(5):340-52, 2002. HAGSTROM, R.M.; BILLINGS, F.T.; CHAPNICK, E.M.; BALL, C.O.T.; MENEELY, G.R. Sudden death in survivors of myocardial infarction. Circulation 30(Suppl. III): III-91-2, 1964. HALE, S. L.; BIRNBAUM, Y.; KLONER, R. A.; ? ? estradiol, but not ?- estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion. Am. Heart. J. v.132, p. 258 ? 262, 1996. HAMILTON M. A.; STEVENSON L. W.; LUU M.; WALDEN J. A. Altered thyroid hormone metabolism in advanced heart failure. J Mol Cell Cardiol 16:91-95, 1990. HAMILTON, M. A. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg. Jul;56(1 Suppl):S48-52; 1993. 86 HARRIS, A. R. C.; VAGENAKIS, A. G.; BRAVERMAN, L. E. Sex-related differences in outer ring monodeiodination of thyroxine and 3,3',5'-triiodothyronine by rat liver homogenates. Endocrinology 104: 645-652, 1979. HEARSE, D.J.; RICHARD, V.; YELLON, D.M.; KINGMAN, J.G. Jr. Evolving myocardial infarction in the rat in vivo: inappropriate model for the investigation of drug-induced infarct size limitation during sustained regional ischemia. J CardiovascPharmacol 11: 701-710, 1988. HEIMBURGER, R.F. Injection into pericardial sac and ligation of coronary artery of the rat. Arch Surg 52: 677-89, 1946. HE H.; GIORDANO F. J.; HILAL-DANDAN R.; CHOI D. J.; ROCKMAN H. A.; McDONOUGH P. M.; LUHM W. F.; MEYER M.; SAYEN M. R.; SWANSON E.; DILLMANN, W.H. Overexpression of the rat sarcoplasmatic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 100: 380-389, 1997. HOIT, B.D.; KHAN ZU, PAWLOSKI-DAHM, C.M.; WALSH, R.A. In vivo determination of left ventrivular wall stress-shortening relationship in normal mice. Am J Physiol 272: H-1047-1052, 1997. HOLT E; SJAASTAD I; LUNDLE PK; CHRISTENSEN G; SJERSTED OM. Thyroid hormone control of contraction and the Ca2+ ATPase/phospholamban complex in adult rat ventricular myocytes. J Mol Cell Cardiol 31:645-656, 1999. HON, E. H.; LEE, S. T. Electronic evaluations of the fetal heart rate pattern preceding fetal death, further observations. Am J Obstet Gynecol;87:814?26, 1965. H?GEL, S.; REINCKE, M.; STROMER, H.; WINNING, J.; HORN, M.; DIENESCH, C.; MORA, P.; SCHMIDT, H. H.; ALLOLIO, B.; NEUBAUER, S. Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. J Am Coll Cardiol;34:1427?34, 1999. JANSE, M.J.; WIT, A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiological Reviews 69: 1049- 169, 1989. JOHNS, T.N.P. & OLSON, J.B. Experimental myocardial infarction: a method of coronary occlusion in small animals . Ann. Surg 140: 675 ? 82, 1954. JOHNSON, A.K.; THUNHORST, R.L. The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanism of central integration. Front Neuroendocrinol 18: 292-353, 1997. 87 JULIAN, D.G. Prognosis, risk stratification and rehabilitation after acute myocardial infarction. In: JULIAN, D.G.; CAMM. A.J.; FOX, K.M.; HALL, R.J.C.; POOLEWILSON, P.A., ed. Diseases of the heart. London, Bailli?reTidall Cap. 51, p. 1192- 1202, 1989. KAASIK A; PAJU K; VETTER R; SEPPET EK. Thyroid hormone increases the contractility but suppresses the effects of beta-adrenergic agonist by decreasing phospholamban expression in rat atria. Cardiovasc Res 35:106-112, 1997. KANNEL, W.B.; SORLIE, P.; McNAMARA, P.M. Prognosis after initial myocardial infarction: the Framingham study. American journal of cardiology 44: 53-9, 1979. KAUFMAN, N; GAVA TL; HILL, RW Experimental myocardial infarction in the rat. Arch. Pathol. Lab. Med., 67: 482 ? 488, 1959. Kelly, M.J. et al. Differential sensitivity of preoptic-septal neurons to microelectrophoresed estrogen during the estrous cycle. Brain Res.114, 152?157, 1976. Kelly, M.J. and Lagrange, A.H. Nontranscriptional effects of estradiol in neuropeptide neurons. Curr. Opin. Endocrinol. Diabetes 5, 66?72, 1998. Kelly, M.J. and Wagner, E.J. Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol. Metab. 10, 369?374, 1999. Kelly, M.J. et al. Hyperpolarization of hypothalamic parvocellular neurons by 17?-estradiol and their identification through intracellular staining with procion yellow. Exp.Brain Res. 40, 440?444, 1980. KEMPF, F.C; JOSEPHSON, M.E. Cardiac arrest recorded on ambulatory electrograms. American Journal of Cardiology 53: 1577-1582, 1984. KISHI, T.; HIROOKA, Y. Central mechanisms of abnormal sympathoexcitation in chronic heart failure. Cardiol Res Pract 2012: 847172, 2012. 88 KISLEY, L. R.; SAKAI, R. R.; FLUHARTY, S. J.; Estrogen decreases hypothalamic angiotensin II AT1 receptor binding and mRNA in the female rat. Brain Res 844: 34-42, 1999. KISS E; JAKAB G; KRANIAS EG; EDES I. Thyroid hormone induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmatic reticulum Ca2+ transport and myocardium relaxation. Circ Res 75:245- 251, 1994. KLAASSEN, C. D. Casarett and Doull?s Toxicology: The basic Science of Poisons. EstadosUnidos da Am?rica: McGraw-Hill Companies, 2001. KLEIN I; OJAMAA K. Thyroid hormone and blood pressure regulation. In: Hypertension: Pathophysiology , Diagnosis, and Management, 2nd ed., editora: JH Laragh e BM Brenner. New York: Raven, p. 2247-2262, 1995. KLEIN I. & OJAMAA K. Thyroid Hormone ? Targeting The Heart. Endocrinology 142: 11-12, 2001. KNEPPER M. A. Long-term regulation of urinary concentrating capacity. Am J Physiol Renal Physiol 275: F332?F333, 1998. K?HRLE, J. Thyroid hormone deiodination in target tissues ? a regulatory role for thetrace element selenium?. Experimental and Clinical Endocrinology 102: 63-89, 1994. KOTLER, M.N.; TABATZNIK, B.; MOWER, M.N.; TOMINAGA, S. Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period. Circulation 47: 959-966, 1973. KRAUSE, E. G.; CURTIS, K. S.; DAVIS, L. M.; STOWE, JR.; CONTRERAS, R. J. Estrogen influences stimulated water intake by ovariectomized female rats. Physiol Behav, 79: 267-274, 2003. LEENEN F. H. Cardiovascular consequences of sympathetic hyperactivity. Can J Cardiol 15, Suppl A: 2A?7A, 1999. 89 LERNER, D. J.; KANNEL, W. B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111: 383?390, 1986. LEONARD, J.L.; K?HRLE, J. Intracellular pathways of iodothyronine metabolism. In: Braverman, L.E.; Utiger, R.D.; Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7a ed, Lippincott-Raven, Philadelphia, pp. 125-161, 1996. LI, H. Y.; BIAN, J. S.; KAWAN, Y. W.; WONG, T. M. Enhanced responses to 17betaestradiol in rat hearts treated with isoproterenol: involvement of a cyclic AMPdependent pathway. J PharmacolExpTher. v.293, p.592-598, 2000. LIEHR, J. G. Is estradiol a genotoxic mutagenic carcinogen? Endocrine .Reviews. v. 21, p. 40-54, 2000. LIMA, H.R.C.; CAVALCANTE-LIMA, H.R., CEDRAZ-MERCEZ, P.L.; COSTA-ESOUSA, R.H.; OLIVARES, E.L.; BADAU?-PASSOS-Jr, D.; MEDEIROS, M.A.; C?RTES, W.S.; REIS, L.C. Brain serotonin depletion enhances the sodium appetite induced by sodium depletion or beta-adrenergic stimulation. An Acad Bras Cienc 76(1):85-92, 2004. LIMA, L.P.; BARROS, I.A.; LISBOA, P.C.; ARAUJO, R.L.; SILVA, A.C.; ROSENTHAL, D.; FERREIRA, A.C.; CARVALHO, D.P. Estrogen effects on thyroid iodide uptake and thyroperoxidase activity in normal and ovariectomized rats. Steroids 71(8): 653-659, 2006. LINZBACH, A J. Heart failure from the point of view of quantitative anatomy. Am J Cardiol 5: 370-82, 1960. LIU, J. L.; ZUCKER, I. H. Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ Res 84: 417?423, 1999. LISB?A, P.C.; CURTY, F.H.; MOREIRA, R.M.; PAZOS-MOURA, C.C. Effects of estradiol benzoate on 5?-iodothyronine deiodinase activities in female rat anterior pituitary gland, liver and thyroid gland. Brazilian Journal of Medical and Biological Research 30:1479-1484, 1997. LISB?A, P.C.; CURTY, F.H.; MOREIRA, R.M.; OLIVEIRA, K.J.; PAZOS-MOURA, C.C. Sex steroids modulate rat anterior pituitary and liver iodothyroninedeiodinase activities. Hormone and Metabolic Research 33:532-535, 2001. 90 LITWIN, S. E.; KATZ, S. E.; MORGAN, J. P.; DOUGLAS, P. S. Serial echocardiographic assessment of the left ventricular geometry and function after large myocardial infarctionin the rat. Circulation 89: 345-54, 1994. LITWIN, S. E.; KATZ, S. E.; MORGAN, J. P.; DOUGLAS, P. S Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J A, Coll Cardiol 28:773-81, 1996. LOMBARDI F, SANDRONE G, PERNPRUNER S. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol 60:1239 ? 45, 1987. MAHMOODZADEH, S.; EDER, S.; NORDMEYER, J.; EHLER, E.; HUBER, O.; MARTUS, P.; WEISKE, J.; PREGLA, R.; HETZER, R.; REGITZ- ZAGROSEK, V. Estrogen receptor alpha upregulation and redistribution in human heart failure. FASEB J. v. 20, p. 926 ? 934, 2006. MALIK M., CAMM A. J., JANSE M. J., JULIAN D. G., FRANGIN G. A., SCHWARTZ P. J. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol;35:1263 ? 75, 2000. MALLORY, G.K.; WHITE, P.D.; SALCEDO-SALGAR, J. The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases. American Heart Journal 18(6): 647-71, 1939. MANGIAPANE M. L.; THRASHER T. N.; KEIL L. C.; SIMPSON J. B.; GANONG W. F. Role for the subfornical organ in vasopressin release. Brain Res Bull 13: 43?47, 1984. MARASSI, M. P.; FORTUNATO, R. S.; DA SILVA, A. C.; PEREIRA, V. S.; CARVALHO, D. P.; ROSENTHAL, D.; DA COSTA, V. M. Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-puberal and adult rats. J Endocrinol; 192(1):121-30, 2007. 91 MARCHLINSKI, F.E.; Ventricular tachycardia: clinical presentation, course and therapy. In: ZIPES, D.P.; JALIFE, J., ed Cardiac electrophysiology. From cell to beside. Philadelphia, W.B. Saunders, P. 82, 1990. McIVER, B.; GORMAN, C. A. Euthyroid sick syndrome: an overview. Thyroid 7:125?132, 1997. MECAWI, A. S.; LEPLETIER, A.; ARAUJO, I. G.; OLIVARES, E. L.; REIS, L. C. Assessment of brain AT1-receptor on the nocturnal basal and angiotensin-induced thirst and sodium appetite in ovariectomised rats. J Renin Angiotensin Aldosterone Syst; 8:169?75, 2007. MECAWI AS, VILHENA-FRANCO T, ARAUJO IG, REIS LC, ELIAS LLK, ANTUNES-RODRIGUES J. Estradiol potentiates hypothalamic vasopressin and oxytocin neuron activation and hormonal secretion induced by hypovolemic shock. Am J Physiol Regul Integr Com Physiol 301: R905-R915, 2011. MEINHARDT, U. & MULLIS, P. E., 2002. The aromatase cytochrome P-450 and its clinical impact. Hormone Research v. 57, p.145-152, 2002. MENDELSOHN, M. E.; KARAS, R. H. The time has come to stop letting the hers tale wag the dogma. Circulation. v. 104, p. 2256 - -2259, 2001. MEREDITH, I. T.; EISENHOFER, G.; LAMBERT, G. W.; DEWAR, E. M.; JENNINGS, G. L. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88: 136?145, 1993. MEYER, R.; LINZ, K. W.; SURGES, R.; MEINARDUS, S.; VEES, J.; HOFFMANN, A.; WINDHOLZ, O.; GROHE, C. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol. v. 83, 305-321, 1998. Migliaccio, A. et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol?receptor complex in MCF-7 cells. EMBO J. 15, 1292?1300, 1996. MILL, J. G.; VASSALLO, D. V.; LEITE, C. M. Time course of changes in heart rate and sympathetic tone after coronary artery ligation in rats. Braz J Med Biol Res; 24: 855-858, 1991. 92 MIYASHITA, K.; MURAKAMI, M.; IRIUCHIJIMA, T.; TAKEUCHI, T.; MORI, M. Regulation of rat type I iodothyroninedeiodinase mRNA levels by testosterone. Mol CellEndocrinol 115: 161-167, 1995. MOREIRA, D.G.; MARASSI, M.P.; CORR?A DA COSTA, V.M.; CARVALHO, D.P.; ROSENTHAL, D. Effects of ageing and pharmacological hypothyroidism on pituitary-thyroid axis of Dutch-Miranda and Wistar rats. Experimental Gerontology 40: 330-334, 2005. MORRIS, D.C.; WALTER, P.F.; HURST, J.W. The recognition and treatment of myocardial infarction and its complications. In: HURST, J.W.; SCHLANT, R.C.; ed. The heart. Arteries and veins. 7 ed. New York, McGraw-Hill, Cap. 53C, p. 1054-1078, 1990. MUSCH, T.I.; MOORE, R.C.; LEATHERS, D.J.; BRUNO, A.; ZELIS, R. Endurance training in rats with chronic heart failure induced by myocardial infarction. Circulation 74(2): 431-441, 1986. NELSON, D. L. & COX, M. M. Lehninger Principles of Biochemistry. Nova York: Worth Publishers, 2000. NICKENIG, G.; BAUMER, A. T.; GROHE, C.; KAHLERT, S.; STREHLOW, K.; ROSEN-KRANZ, S.; STABLEIN, A.; BECKERS, F.; SMITS, J. F.; DAEMEN, M. J.; BOHM, M. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197?2201, 1998. NORMAN, T.D. & COERS, C.R. Cardiac hypertrophy after coronary artery ligation in rats. Archives of Pathology 69: 69-72, 1960. NORRIS, R.M.; CAUGHEY, D.E.; MERCER, C.J.; SCOTT, P.J. Prognosis after myocardial infarction. Six-yearfollowup. British Heart Journal 36: 786-90, 1974. NOVAES, M.A.S. Estudo das altera??es morfol?gicas e funcionais do m?sculo papilar do ventr?culo esquerdo de ratos submetidos ao infarto do mioc?rdio. Vit?ria, Departamento de Ci?ncias Fisiol?gicas da Universidade Federal do Esp?rito Santo, 1992.92p. (Tese, Mestrado). OJAMAA, K.; KENESSEY, A.; SHENOY, R.; KLEIN, I. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J PhysiolEndocrinolMetab 279: E1319-E1324, 2000. 93 OLIVARES, E.L.; COSTA-E-SOUSA, R.H.; CAVALCANTE-LIMA, H.R.; LIMA, H.R.C.; CEDRAZ-MERCEZ, P.L.; REIS, L.C. Effect of electrolytic lesion of the dorsal raphe nucleus on water intake and sodium appetite. Braz J MedBiol Res 36(12): 1709- 1716, 2004. OLIVARES E. L.; MARASSI M. P.; FORTUNATO R. S.; SILVA A. C. M.; COSTAE- SOUSA R. H.; ARAUJO I. G.; MATTOS E. C.; MASUDA M. O.; MULCAHEY M. A.; HUANG S. A.; BIANCO A. C.; CARVALHO D. P. Thyroid function disturbance and type 3 iodothyroninedeiodinase induction after myocardial infarction in rats ? a time course study. Endocrinology, v.148(10): 4786-92, 2007. OLIVETTI, G; RICCI, R; BEGHI, C; GUIDERI, G; ANVERSA, P. Response of the border zone to myocardial infarction in rats. American Journal of Pathology 125(3): 476-83, 1986. OLIVETTI, G; CAPASSO, J.M.; MEGGS, L.G.; SONNENBLICK, E.H.; ANVERSA, P. Cellular basis of chronic left ventricular remodeling after myocardial infarction in rats. Circulation Research 68(3): 856-69, 1991. OSAWA, Y.; HIGASHIYAMA, T.; SHIMIZU, Y. & YARBOROUGH, C., Multiple functions of aromatase and the active site structure: aromatase is the placental estrogen 2-hydroxilase. The Journal of Steroid Biochemistry and Molecular Biology . v. 44, p. 469-480, 1993. PACKER, M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248?254, 1992. PANCIERA, D. L.; REFSAL, K. R. Thyroid function in dogs with spontaneous and induced congestive heart failure. Can J Vet Res. Jul;58(3):157-62, 1994 . PANIDIS, I.; MORGANROTH, J. Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. Journal of the American College of Cardiology 2: 798-805, 1983. PATEL, K. P. Role of paraventricular nucleus in mediating sympathetic outflow in heart failure. Heart Fail Rev 5: 73?86, 2000. PAZOS-MOURA, C.; ABEL, E.D.; BOERS, M.E., MOURA, E.; HAMPTON T.G.; WANG J; MORGAN J.P.; WONDISFORD F.E. Cardiac Dysfunction Caused by 94 Myocardium-Specific Expression of a Mutant Thyroid Hormone Receptor. Circ Res.; 86: 700-6, 2000. PEREIRA-JUNIOR PP, CHAVES EA, COSTA ESRH, MASUDA MO, DE CARVALHO AC, NASCIMENTO JH Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol; 96: 487-494, 2006. PETTERSSON, K.; GRANDIEN, K.; KUIPER, G. G. & GUSTAFSSON, J. A. Mouse estrogen receptor ? forms estrogen response element-binding heterodimers with estrogen receptor ?. Molecular Endocrinology, v. 11, p. 1486 ? 1496, 1997. PFEFFER, M.A., PFEFER, J.M.; FISHBEIN, M.C.; FLETCHER, P.J., SPADARO, J., KLONER, R.A., BRAUNWALD, E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979. PFEFFER, M.A.; PFEFER, J.M.; STEINBERG, C., FINN, P. Survival after an experimental myocardial infarction: beneficial effects of long term therapy with captopril. Circulation 72: 406-12, 1985. PFEFFER, J.M.; BRAUNWALD, E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81(4): 1161-1172, 1990. PFEFFER, J.M.; PFEFER, M.A; FLETCHER, P.J., BRAUNWALD, E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol 260: H1406- H1414,

Page generated in 0.0302 seconds